1) Barrett JC:Mechanisms of multistep carcinogenesis and carcinogen risk assessment. Environ Health Perspect 100:9-20, 1993
2) 及川伸二,川西正祐:発癌過程における微量金属の役割.微量金属の生体作用―季刊化学総説No27,(日本化学会編),pp93-106, 1995
3) Yamamoto S, Konishi Y, Matsuda T, et al:Cancer induction by an organic arsenic compound, dimethylarsinic acid(cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens. Cancer Res 55:1271-1276, 1995
4) 福田浩之,江原正明,山田博之,他:微量元素と癌.日医雑誌 129:646-648, 2003
5) Navarro Silvera SA, Rohan TE:Trace elements and cancer risk:a review of the epidemiologic evidence. Cancer Causes Control 18:7-27, 2007
6) Pramoolsinsap C, Promvanit N, Komindr S, et al:Serum trace metals in chronic viral hepatitis and hepatocellular carcinoma in Thailand. J Gastroenterol 29:610-615, 1994
7) Ebara M, Fukuda H, Hatano R, et al:Relationship between copper, zinc and metallothionein in hepatocellular carcinoma and its surrounding liver parenchyma. J Hepatol 33:415-422, 2000
8) Ebara M, Fukuda H, Hatano R, et al:Metal contents in the liver of patients with chronic liver disease caused by hepatitis C virus. Reference to hepatocellular carcinoma. Oncology 65:323-330, 2003